Does Resistance Training Provide Benefits that Are Comparable to Aerobic Exercise in Hypertension?

IF 6.3 2区医学 Q1 PERIPHERAL VASCULAR DISEASE

Current Hypertension Reports Pub Date : 2026-04-10 DOI:10.1007/s11906-026-01369-4

Hirofumi Tanaka, Rodrigo Ferrari

引用次数: 0

Abstract

PURPOSE OF REVIEW: Historically, blood pressure (BP) guidelines emphasized the implementation of aerobic exercise. However, more recent guidelines started highlighting the benefits of resistance exercise. The primary aim of this brief review is to determine if resistance training offers comparable benefits to aerobic exercise on BP in individuals with hypertension. RECENT FINDINGS: Aerobic exercise training consistently produces the greatest effect, lowering systolic/diastolic BP by ~ 7/5 mmHg in individuals with hypertension. Dynamic resistance training elicits more modest reductions (~ 2/2 mmHg), whereas isometric resistance training, though evaluated in fewer and smaller studies, has shown clinically meaningful reductions of ~ 5/5 mmHg. However, the impacts of resistance exercise training on ambulatory BP remain non-significant and marginal. Strategies to reduce BP should prioritize aerobic exercise rather than resistance training, especially when the primary goal is BP management.

查看原文本刊更多论文

抗阻训练对高血压的疗效与有氧运动相当吗？

回顾目的：历史上，血压（BP）指南强调有氧运动的实施。然而，最近的指南开始强调阻力运动的好处。这篇简短综述的主要目的是确定阻力训练是否对高血压患者的血压有与有氧运动相当的益处。最近的研究发现：有氧运动训练持续产生最大的效果，降低高血压患者的收缩压/舒张压约7/5 mmHg。动态阻力训练可引起更适度的降低（~ 2/2 mmHg），而等长阻力训练，虽然在更少和更小的研究中进行了评估，但显示出有临床意义的~ 5/5 mmHg的降低。然而，阻力运动训练对动态血压的影响仍然不显著和边缘。降低血压的策略应该优先考虑有氧运动而不是阻力训练，特别是当主要目标是血压管理时。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Hypertension Reports 医学-外周血管病

CiteScore

10.50

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hypertension. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antihypertensive therapies, associated metabolic disorders, and therapeutic trials. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.